DE69939027D1 - Synthese von histamin-dihydrochlorid - Google Patents

Synthese von histamin-dihydrochlorid

Info

Publication number
DE69939027D1
DE69939027D1 DE69939027T DE69939027T DE69939027D1 DE 69939027 D1 DE69939027 D1 DE 69939027D1 DE 69939027 T DE69939027 T DE 69939027T DE 69939027 T DE69939027 T DE 69939027T DE 69939027 D1 DE69939027 D1 DE 69939027D1
Authority
DE
Germany
Prior art keywords
histamine dihydrochloride
invention disclosed
synthesis
dihydrochloride
smallcaps
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69939027T
Other languages
German (de)
English (en)
Inventor
Wen-Lung Yeh
Casimir Antczak
Jeffry David Mcgolrick
Michael Joseph Roth
Mark Wrona
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Maxim Pharmaceuticals Inc
Original Assignee
Maxim Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maxim Pharmaceuticals Inc filed Critical Maxim Pharmaceuticals Inc
Application granted granted Critical
Publication of DE69939027D1 publication Critical patent/DE69939027D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/145555—Hetero-N
    • Y10T436/147777—Plural nitrogen in the same ring [e.g., barbituates, creatinine, etc.]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69939027T 1998-12-23 1999-12-20 Synthese von histamin-dihydrochlorid Expired - Lifetime DE69939027D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11393398P 1998-12-23 1998-12-23
PCT/US1999/030379 WO2000039098A1 (en) 1998-12-23 1999-12-20 Synthesis of histamine dihydrochloride
US09/467,652 US6403806B1 (en) 1998-12-23 1999-12-20 Synthesis of histamine dihydrochloride

Publications (1)

Publication Number Publication Date
DE69939027D1 true DE69939027D1 (de) 2008-08-14

Family

ID=26811642

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69939027T Expired - Lifetime DE69939027D1 (de) 1998-12-23 1999-12-20 Synthese von histamin-dihydrochlorid

Country Status (17)

Country Link
US (3) US6403806B1 (enExample)
EP (1) EP1140857B1 (enExample)
JP (1) JP4139082B2 (enExample)
CN (1) CN1155579C (enExample)
AT (1) ATE399769T1 (enExample)
AU (1) AU763523B2 (enExample)
CA (1) CA2356871C (enExample)
DE (1) DE69939027D1 (enExample)
DK (1) DK1140857T3 (enExample)
ES (1) ES2310056T3 (enExample)
HK (1) HK1040998B (enExample)
IL (2) IL143570A0 (enExample)
NZ (1) NZ512935A (enExample)
PT (1) PT1140857E (enExample)
TW (1) TWI243166B (enExample)
WO (1) WO2000039098A1 (enExample)
ZA (1) ZA200104552B (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6590106B2 (en) * 1997-05-09 2003-07-08 Pharm-Eco Laboratories, Inc. Amino acid derivatives and methods of making the same
US7728015B2 (en) * 2004-04-22 2010-06-01 Mor Research Applications Ltd. Compositions for weight management
WO2005101979A2 (en) * 2004-04-22 2005-11-03 Mor Research Applications Ltd. Method of food intake management
US20080051440A1 (en) * 2004-04-22 2008-02-28 Mor Research Applications Ltd. Compositions for weight management
US20060188528A1 (en) * 2005-02-23 2006-08-24 Ansell Healthcare Products Llc Spreadable warming lubricant
US7709428B2 (en) * 2005-02-23 2010-05-04 Ansell Healthcare Products Llc Thickened spreadable warming lubricant
DE102006060908A1 (de) * 2006-12-20 2008-07-03 Evonik Degussa Gmbh Kontinuierliches Verfahren zur Decarboxylierung von Carbonsäuren
US8770201B2 (en) * 2007-10-26 2014-07-08 Glycobiosciences Inc. Condom with multifunctional coating
CN102477014B (zh) * 2010-11-27 2015-08-19 山东新时代药业有限公司 二盐酸组胺的制备方法
ITMI20110379A1 (it) * 2011-03-10 2012-09-11 Erregierre Spa Procedimento per la preparazione di istamina dicloridrato con elevato grado di purezza
US9452954B2 (en) 2013-03-14 2016-09-27 University Of Georgia Research Foundation, Inc. Method for decarboxylation of amino acids via imine formation
US10487042B2 (en) 2013-03-14 2019-11-26 University Of Georgia Research Foundation, Inc. Method for solvent-free decarboxylation of amino acids via imine formation
US10118898B2 (en) 2013-03-14 2018-11-06 University Of Georgia Research Foundation, Inc. Method for decarboxylation of amino acids via imine formation
CN103288742A (zh) * 2013-06-04 2013-09-11 四川百利药业有限责任公司 一种高纯度英加韦林原料的制备方法
CN103739551B (zh) * 2013-09-24 2016-03-23 国药一心制药有限公司 一种二盐酸组胺的纯化方法
JP6495288B2 (ja) 2013-12-17 2019-04-03 サイモン フレーザー ユニバーシティー トコジラミを誘引および／または拘束するための化合物、組成物、および方法
CN103739552B (zh) * 2014-01-24 2015-08-26 国药一心制药有限公司 二盐酸组胺的制备方法
CN104402825B (zh) * 2014-12-13 2017-03-15 济南诚汇双达化工有限公司 一种组胺二盐酸盐的合成方法
CN106432089B (zh) * 2016-09-12 2018-09-07 开封制药(集团)有限公司 二盐酸组胺的合成方法
US10889549B2 (en) 2017-07-03 2021-01-12 Jubilant Generics Limited Continuous process for the preparation of 2-(1H-imidazol-4-yl) ethanamine and pharmaceutically acceptable salts thereof
WO2019008594A1 (en) * 2017-07-03 2019-01-10 Jubilant Generics Limited CONTINUOUS PROCESS FOR THE PREPARATION OF 2- (1H-IMIDAZOL-4-YL) ETHANAMINE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS
CN112266360B (zh) * 2020-10-26 2022-06-10 武汉桀升生物科技有限公司 一种高纯度组胺二盐酸盐的合成方法
CN113045500A (zh) * 2021-03-31 2021-06-29 苏州园方生物科技有限公司 一种组胺二盐酸盐的制备方法
JP7193815B1 (ja) 2021-12-28 2022-12-21 Ｋｍバイオロジクス株式会社 ヒスタミンの製造方法及び医薬品としてのその使用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE57638C (de) O. ECKARDT in Berlin j N.W., Bandelslr. 14 Verfahren zur Herstellung von Steinkohlenbriquettes auf kaltem Wege
GB430108A (en) * 1934-02-23 1935-06-13 Boot S Pure Drug Company Ltd Improvements relating to the preparation of histamine and its derivatives
GB1008594A (en) 1963-07-03 1965-10-27 Nat Res Dev Process for the production of amines
SU557755A3 (ru) * 1968-08-19 1977-05-05 Янссен Фармасьютика Н.В. (Фирма) Способ получени производных имидазола
DE3322117A1 (de) * 1983-06-20 1984-12-20 Diamalt AG, 8000 München Verfahren zur herstellung von n(pfeil hoch)(tau)(pfeil hoch)-substituierten histidinderivaten, n(pfeil hoch)(tau)(pfeil hoch)-substituierten histidinderivate und ihre verwendung
NL8800998A (nl) * 1988-04-18 1989-11-16 Cedona Pharm Bv Werkwijze voor het bereiden van een al of niet gesubstitueerd 4(5)-(omega-aminoalkyl) imidazool.
JPH05255204A (ja) * 1992-03-11 1993-10-05 Kanegafuchi Chem Ind Co Ltd アミン類の製造法
SE513429C2 (sv) 1992-06-03 2000-09-11 Syntello Inc Preparat för aktivering av naturliga mördarceller, vilket preparat innehåller interferon alfa och biogena aminer

Also Published As

Publication number Publication date
US6528654B2 (en) 2003-03-04
EP1140857A1 (en) 2001-10-10
ZA200104552B (en) 2002-01-16
US6620942B2 (en) 2003-09-16
CA2356871A1 (en) 2000-07-06
DK1140857T3 (da) 2008-10-20
TWI243166B (en) 2005-11-11
AU763523B2 (en) 2003-07-24
HK1040998B (en) 2009-04-24
EP1140857B1 (en) 2008-07-02
CA2356871C (en) 2010-09-14
US6403806B1 (en) 2002-06-11
AU2482500A (en) 2000-07-31
IL143570A (en) 2006-08-20
CN1331681A (zh) 2002-01-16
JP2002533445A (ja) 2002-10-08
IL143570A0 (en) 2002-04-21
ATE399769T1 (de) 2008-07-15
NZ512935A (en) 2003-08-29
PT1140857E (pt) 2008-10-06
HK1040998A1 (en) 2002-06-28
US20020035268A1 (en) 2002-03-21
ES2310056T3 (es) 2008-12-16
WO2000039098A9 (en) 2001-05-17
JP4139082B2 (ja) 2008-08-27
WO2000039098A1 (en) 2000-07-06
CN1155579C (zh) 2004-06-30
US20030138964A1 (en) 2003-07-24

Similar Documents

Publication Publication Date Title
DE69939027D1 (de) Synthese von histamin-dihydrochlorid
PL392725A1 (pl) Nowe związki pośrednie do syntezy związków triazolopirymidyny oraz sposób ich wytwarzania
HUP0001539A2 (hu) 2-(1-Imino-etil-amino)-etil-homocisztein, eljárás előállítására és az ezt tartalmazó gyógyszerkészítmények
GEP20022678B (en) Bicyclic Heteroaromatic Compounds As Protein Tyrosine Kinase Inhibitors, their Pharmaceutical compositions and methods for Treatment
ATE218552T1 (de) 1,2,4-TRIAZIN DERIVAT, DESSEN HERSTELLUNG UND DESSEN VERWENDUNG ALS REFERENZMARKER UM DIE REINHEIT UND STABILITÄT VON ßLAMOTRIGINß ZU BESTIMMEN
HUP0002031A3 (en) Use of benzotiophen derivatives for production pharmaceutical compositions having activity against central nervous system disorders
ATE218341T1 (de) Zwischenverbindungen von fortgeschrittenen glykosylierung-endprodukten und post-amadorische inhibitor
ATE249435T1 (de) Neue kristalline form gamma des tert-butylamin salzes von perindopril, verfahren zu deren herstellung und dieses enthaltende arzneimittel
IL114599A (en) Substituted pyrimidine compounds their preparation and pharmaceutical compositions containg them
ATE219764T1 (de) Zimtsäurederivate und deren verwendung als integrin-antagonisten
FI20011852A7 (fi) Menetelmä fluoksetiinia tai sen happoadditiosuolaa sisältävän dispergoituvan tabletin valmistamiseksi
NO20051689L (no) Substituerte piperaziner, (1,4) diaszepiner og 2,5-diazabicyklo(2.2.1) heptaner som histamin H1 og/eller H3 antagonister eller histamin H3 revers antagonister
MX9605915A (es) Derivados de piperazina como antagonistas de 5ht1a.
HUP0001945A3 (en) Dibenzocycloheptene derivatives as vitronectin receptor antagonists, process for producing them and pharmaceutical copositions containing them
PL316239A1 (en) Heterocyclic compounds, their production and application
WO2004054973A3 (en) Piperidine and pyrrolidine derivatives as antagonists of histamine h3 receptor
WO2001010816A3 (de) Substituierte 2-Dialkylaminoalkylbiphenyl-derivate
WO2006053039A3 (en) Hydroxybenzoate salts of metanicotine compounds
HUP0101143A3 (en) Pyridin-carboxylic acid derivatives as vitronectin receptor antagonists, process for producing them and pharmaceutical compositions containing them
HUP0003641A3 (en) Dibenzocycloheptene derivatives as vitronectin receptor antagonists, process for producing them and pharmaceutical compositions containing them
SE0100824D0 (sv) Method III to obtain microparticles
WO1994019343A3 (en) Novel use as anti-inflammatory agents for bis-heterocyclic compounds and pharmaceutical compositions thereof
CY1108379T1 (el) Συνθεση της διυδροχλωρικης ισταμινης
PT1025101E (pt) Derivados de nafto-imidazo¬1,2-a|piridina sua preparacao e uso no tratamento de perturbacoes do sistema nervoso central
AU1271897A (en) N-protected/n-substituted-beta-amino hydroxy sulfonates

Legal Events

Date Code Title Description
8364 No opposition during term of opposition